Allergen immunotherapy: A long-term perspective

R. Patterson*, L. C. Grammer

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

6 Scopus citations


Efficacy of standard IT to reduce medications and symptoms by at least 50% has been demonstrated multiple times. Reports of negative studies of IT deserve only evaluation of why the study design failed to demonstrate efficacy. Emphasis in the US and worldwide should be on education on the appropriate use of allergen IT, improvements in IT therapy, and preparation for the increased demand for allergists-immunologists as Fellowship training programs decline in numbers and individual training slots decrease.

Original languageEnglish (US)
Pages (from-to)315-316
Number of pages2
JournalAnnals of Allergy, Asthma and Immunology
Issue number4
StatePublished - 1999

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Allergen immunotherapy: A long-term perspective'. Together they form a unique fingerprint.

Cite this